A case-control study was conducted within Group Health Cooperative of Puget Sound to evaluate the relation between prior vasectomy and the risk of prostate cancer. Cases consisted of 175 men newly diagnosed with histologically confirmed prostate cancer during 1989-1991. A total of 258 controls, matched to cases on birth year and membership status, were randomly selected from the general membership of the plan. Information was collected from mailed questionnaires and medical records on medical history, including prior vasectomy, anthropometric measures, family history of prostate cancer, personal habits, and medical care utilization, and demographic factors. Conditional logistic regression analyses showed that the odds ratio for prostate cancer associated with vasectomy was 0.86 (95% confidence interval 0.57-1.32) after adjustment for confounders. The odds ratio estimate did not differ substantially by age at vasectomy or time since vasectomy. However, the odds ratio estimate for prostate cancer associated with vasectomy tended to be increased among men who had a father or brother with prostate cancer. Nevertheless, the increased risk may be related to detection bias or differential participation rates due to both vasectomy status and a family history of prostate cancer. These results suggest no overall association between vasectomy and prostate cancer. Am J Epidemiol 1996;144:717-22.
tween vasectomy and prostate cancer. The results of the case-control studies have been inconsistent; five studies have reported a positive association (2, (4) (5) (6) 8) , one a negative association (1), and three little or no association (3, 7, 9) . Conflicting results have also been reported from the cohort studies; Massey et al. (10) , Sidney et al. (11) , and Nienhuis et al. (12) found no association between vasectomy and prostate cancer risk, while Giovannucci et al. (13, 14) found modestly increased relative risks.
The results on the risk of prostate cancer in relation to time since vasectomy and age at vasectomy have also been inconsistent. Some studies (2, 4, 7, 13, 14) , but not all (5, 11) , have observed an increased risk of prostate cancer in men whose vasectomy took place relatively long ago. Sidney et al. (11) found no difference in prostate cancer risk according to age at vasec-717 718 Zhu et al.
tomy. However, Hayes et al. (7) found that men who had been vasectomized at age 34 years or younger experienced a higher risk for prostate cancer, while men who had undergone a vasectomy at age 35 years or older did not have an increase in risk. In contrast, Giovannucci et al. (14) found an increase in risk for men who had a vasectomy at age 40 years or older.
Apart from chance, methodological limitations such as selection bias, misclassification of vasectomy status, detection bias, and failure to control for potential confounding factors may account for observed differences in results across studies (15) (16) (17) (18) . We sought to provide additional data bearing on this question with the use of a population-based case-control design.
MATERIALS AND METHODS
The study was conducted at Group Health Cooperative of Puget Sound (GHC), a consumer-directed health maintenance organization established in 1947 that provides medical care to approximately 370,000 persons in western Washington State (19) . The GHC population is demographically similar to that of the surrounding community (19) . Comprehensive prepaid health care coverage offered by GHC includes contraception and sterilization services (20) .
All men aged 40-69 years with a primary prostate cancer newly diagnosed at GHC between January 1, 1989 and December 31, 1991 were eligible as cases for the study. All of these primary prostate cancers were histologically confirmed. Information on stage of disease was collected from the Cancer Surveillance System (CSS) of Western Washington, which is part of the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) program. In the SEER program, staging information is based on pathological data where available or clinical modalities such as digital rectal examination and prostatic specificantigen. The stage of prostate cancer was defined in terms of the Whitmore system (21, 22) . Tumor grade was collected from pathological reports and was classified by the Gleason system, with a score of £4 considered well differentiated, a score of 5-7 moderately differentiated, and a score of 8-10 poorly differentiated (23) .
The control group consisted of two randomly selected GHC enrol lees without a history of prostate cancer matched to each case. The matching criteria included year of birth, membership status at reference date (the date of prostate cancer diagnosis for cases and the corresponding date for matched controls), length of GHC enrollment, and the GHC clinic or hospital where the case received his primary medical care. From the computerized membership files at GHC, we assigned a random number to each GHC enrollee who met the matching criteria for a case, and selected the enrollees with the lowest two random numbers to serve as controls.
A total of 272 eligible prostate cancer cases were diagnosed at GHC during 1989-1991. Seventeen cases were excluded because of missing information on matching variables or failure to identify any matched controls. For the remaining 255 cases, 500 matched controls were selected. Physicians' consents to contact their patients were sought for the 255 cases and obtained for 232 of them. The 232 cases and 456 controls matched to them were then sent a questionnaire. The questionnaire was completed by 186 cases (73 percent of 255 eligible cases) and 322 controls (71 percent of the 456 matched controls approached). Of these, 175 cases and 258 matched controls were included in the analysis after exclusion of 11 cases and 64 controls who responded to the mailed survey, but whose matched controls or cases, respectively, failed to respond. The mean ages at reference date were 64.0 and 64.2 years (standard deviations 4.6 and 4.5 years) for the case and control subjects, respectively.
We reviewed all outpatient and inpatient medical records of subjects who participated in the mailed questionnaire survey, who did not respond to the study questionnaire, who had died, or whose doctor's consent was not available. Information from medical records was abstracted by one abstractor using a standard data collection form.
Information collected from mailed questionnaires and medical record reviews included the exposure variable (history of vasectomy), potential confounding variables (demographic factors, reproductive factors, medical history, family history of prostate cancer in first-degree relatives, and health habits), and variables potentially related to the detection of prostate cancer (hospitalization, routine physical examination, digital rectal examination, and ultrasound of the prostate). For men who had undergone a vasectomy, information was collected on date of procedure, age at procedure, and clinic or hospital where the procedure was performed. For a history of benign prostatic hyperplasia or prostatitis, exposure was defined as a physician diagnosis of benign prostatic hyperplasia or prostatitis that occurred S2 years prior to the diagnosis of prostate cancer.
Conditional logistic regression analysis was used to estimate odds ratios and corresponding 95 percent confidence intervals (24, 25) . A history of vasectomy was compared between cases and controls. In this study, none of the subjects had a vasectomy performed within the 5 years before reference date. Other factors were evaluated one at a time for their effect on the odds ratio for the association of vasectomy with prostate cancer. If the odds ratio estimate for vasectomy changed by 10 percent or more after controlling for a factor, subsequent odds ratio estimates were adjusted for the factor. The potential confounding factors evaluated included marital status, age at first marriage, years of marriage, race, religion, occupation, education, annual family income, number of children, cigarette smoking, alcohol use, physical activity, weight at reference date, weight at age 18 years, height, Quetelet index (weight (kg)/height (m)
2 ) at reference date and at age 18 years, history of genitourinary diseases (benign prostatic hyperplasia, prostatitis, epididymitis/ orchitis, kidney stones, and inguinal hernia), history of sexually transmitted diseases, history of other cancers, and family history of prostate cancer.
We scrutinized the correlations between the two data sources. Among the 17 cases who reported that their vasectomy had been performed at GHC, 14 could be confirmed from medical records (82.4 percent). Fifteen of the 16 controls (93.8 percent) who claimed to have undergone a vasectomy at GHC had medical record documentation of this. Because the procedures performed outside of GHC would not necessarily have been expected to have been recorded in the medical charts, only information from mailed questionnaires was used for the vasectomy history in the data analysis. For history of the aforementioned diseases and family history of prostate cancer, analyses were also based on information provided in the mailed questionnaire because there was a lack of good agreement between the mailed questionnaire and medical records (data not shown). However, we also repeated the analyses using two separate variables indicating different data sources of a factor to examine whether the results were consistent with those based on the mailed questionnaire only. For the rest of the factors (marital status, occupation, race, number of children, weight, and height), missing values in the questionnaire data were replaced by the corresponding data from medical records, based on a good agreement (the value of kappa index or correlation coefficient ^0.8) between the two data sources (data not shown). Table 1 presents a comparison of selected demographic and medical history characteristics of the cases and controls. No appreciable differences were found in the distributions of marital status, race, education, and annual family income. The two groups were also similar according to religion, occupation, and number of children (data not shown). However, cases were more likely to have a family history of prostate cancer than controls.
RESULTS
The prevalences of vasectomy among cases and controls were 34.9 percent and 36.0 percent, respectively (odds ratio (OR) = 0.97, 95 percent confidence interval (CI) 0.65-1.46, adjusted only for the matching variables). The history of prostate cancer in a firstdegree relative (i.e., father or brothers) was identified as a potential confounding variable in terms of our criterion. Further adjustment for this variable decreased the odds ratio for vasectomy to 0.86 (95 percent CI 0.57-1.32) (table 2). The results were also similar when two separate variables indicating different data sources were used for family history of the disease (OR = 0.83, 95 percent CI 0.54-1.27).
In cases and controls, the average ages at which vasectomy was performed were 36.5 years and 37.6 years, and the average times since vasectomy were 26.2 years and 25.8 years, respectively. There was no association with prostate cancer in any subgroup defined by age at vasectomy or time since vasectomy (table 2) .
The relation between prostate cancer and vasectomy also was evaluated in terms of stage of disease and Gleason score. There were 112 cases who had stage A/B and 49 who had stage C/D. The number of patients was 47, 108, and 11 for Gleason scores 2-4, 5-7, and 8-10, respectively. We combined the two groups with Gleason scores 5-7 and 8-10 due to the small number of cases in the latter category. The relative risk estimates were slightly higher among men with early stage (OR = 0.94 for A and B vs. OR = 0.73 for C and D) or well differentiated (OR = 1.25 for Gleason score 2-4 vs. OR = 0.67 for Gleason score 5-10) prostate cancer. However, confidence intervals of all of the odds ratios were wide.
The odds ratio for the vasectomy-prostate cancer association was calculated for subgroups according to family history of prostate cancer and age at diagnosis. The relative risk estimates were somewhat different according to family history of prostate cancer (table  3) . A history of vasectomy in men without a family history was not associated with.risk (OR = 0.75, 95 percent CI 0.47-1.20). Among men with a family history of prostate cancer, however, the risk was slightly increased (OR = 1.62, 95 percent CI 0.60-4.33) (p for the interaction = 0.16).
DISCUSSION
In comparison with some earlier case-control studies, our study had several strengths. The study was population-based, and it was conducted in a population in which vasectomy was relatively common. Therefore, it was less likely to be prone to admission bias in hospital-based case-control studies and insufficient study power. Reported history of vasectomy appeared to be accurate, because the majority of selfreported procedures performed at GHC could be con- firmed from the patients' medical records. Further, this study collected data on family history of prostate cancer and medical history as potential confounding factors.
Our study also had several limitations which should be considered. Twenty-seven percent of cases and 29 percent of controls did not complete the mailed questionnaire. We also could not evaluate the potential confounding effect of dietary intake, which was not measured in the study. Furthermore, misclassification of disease status due to undetected prostate cancers in the control group to some extent may have diluted a true vasectomy-prostate cancer association.
In this study population, the overall estimated relative risk of prostate cancer related to vasectomy was not different from unity (OR = 0.86, 95 percent CI 0.57-1.32) after adjustment for confounding variables. No associations were observed with age at vasectomy or time since vasectomy. The relative risk estimates varied to only a small degree across different subgroups defined by stage or Gleason score. However, we found a suggestion of an increased risk of prostate cancer associated with vasectomy among men with a positive family history of prostate cancer. This risk may be increased because men with both vasectomy and a family history of prostate cancer might be under increased surveillance for prostate cancer. This is supported by our observation that the increased risk associated with vasectomy among men with a family history of prostate cancer appeared to be confined to early-stage or low-grade tumors (data not shown). However, it is also possible that the increased risk is the result of differential participation rates in our study, because medical records showed that subjects with both a history of vasectomy and a family history of prostate cancer were more likely to participate, and cases with early-stage tumors were also more likely to participate (data not shown). Because of the under ascertainment of vasectomy history and inaccuracy of family history in medical records, however, not too much weight should be placed on comparisons based on these records alone. We recommend further evaluation of these patterns in future studies.
It is possible that men who have a history of vasectomy may be under greater medical surveillance as a result of prior urologic surgery, and they may have more concerns about their health. As a result of the enhanced contact with providers of medical care, more prostate cancers may come to clinical diagnosis among vasectomized men (4, 5, 26) . If detection bias exists, higher odds ratio estimates should be observed among patients with early-stage or low-grade disease. In our study, the relative risk estimates for prostate cancer were only slightly higher for early-stage or low-grade tumors compared with more advanced disease. Among controls, there also were no overall differences in the frequency of digital rectal examination or routine physical examination between men with and without a history of vasectomy (data not shown). However, the results of the vasectomy/prostate-cancer association for early-stage or low-grade tumors suggest that detection bias due to a combination of vasectomy and family histories could be present.
Because of the high incidence rate of prostate cancer and the widespread use of vasectomy, it would be important to determine whether there is a relation between the two. While the results of our study and those of several other studies suggest that men who have had a vasectomy have no higher risk of prostate cancer, there are enough studies that have observed a positive association to prevent any definitive conclusion from being drawn at the present time.
